{"name":"CARE ARTHRITIS LTD.","slug":"care-arthritis-ltd","ticker":"","exchange":"","domain":"","description":"CARE ARTHRITIS LTD. is a specialty pharmaceutical company focused on the development and commercialization of innovative treatments for arthritis. The company's lead product, Upadacitinib 15 MG [Rinvoq], is currently marketed for the treatment of rheumatoid arthritis.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-17","type":"regulatory","source":"Medical Dialogues","summary":"Sun Pharma's ILUMYA Gets USFDA Review Nod for Psoriatic Arthritis Indication - Medical Dialogues","headline":"Sun Pharma's ILUMYA Gets USFDA Review Nod for Psoriatic Arthritis Indication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNQmtKU0Q5c25lMl9LblRFeUZuSTNBWmYxOXlmV0VfSGVCOGJRMEp3U3lIN2lIMkxLek56STU1b1VfREVWTXdVckxCTmVhU05VSnlSM2NUandmSWlyNkpuOHUwY1NUZGFjdVJ4Tm4yRWdma05KcUl6NVNkSDZmaEdZWkFTQ3FJZ2ppSWpCNjV1MFNkczhJaU5XTlZiUlRqNXA4VFBfT3FtU0xXT3VjY0hHa2k2cGlPVEFMNTdzM0FrdVJJRFdIOHRMcEg4Y2h4bEc2TnVRMzdfTHI?oc=5","date":"2026-01-13","type":"trial","source":"BioPharma APAC","summary":"Lynk Pharmaceuticals Delivers Breakthrough Phase Three Win For Oral Rheumatoid Arthritis Therapy - BioPharma APAC","headline":"Lynk Pharmaceuticals Delivers Breakthrough Phase Three Win For Oral Rheumatoid Arthritis Therapy","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-11-19","type":"regulatory","source":"Medical Dialogues","summary":"Biocon Pharma gets USFDA nod for arthritis drug Tofacitinib ER - Medical Dialogues","headline":"Biocon Pharma gets USFDA nod for arthritis drug Tofacitinib ER","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNcG1IcVpOVExYUG1XSVNJaGFNNzJVcXFoWVJKMDFTaHBJNi1DX2dxOE80azlSUHdtRHIzNTZ6dXhEUXFDcl9HVGYxRWZpekVTY1MtVXRqV2lkb2l5bEFWZlQzbE5lT2pSY3BDaU1nQkllOEZ1Snk3Q3lnb1dPRzdPWkR6ZFVKLW1YUWZsZHgxS2ZMa0JybXBmcXlOdXRfTThuX0JwMkhBVGhhTU1lNEVwODBjM1pQQjRKb2NBeXl4V1pVZEI4NW1URVNlajQ5ZVZKcWtEb3o1eVgtdkh3TXhSTFhScEpZaGlUdUhtR09zU2JFY0Q3VllKa00ySXRqMVV4WlJEN0tQbmtKalp6U2dCaEpxblhJYzJTVDEwTXU0OXNWNWxQbXJ5Wk5XRk9jY3FqY3EyaElUdUI?oc=5","date":"2025-11-06","type":"patent","source":"Finansavisen","summary":"Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA - Finansavisen","headline":"Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQNDFqMUwwdjEtSkI5OHJKT1BPOXVKZVluVERHRWVZN2JOZjJlNFNDYVZOMFhjVk40NjJ4RXBhT1ZmMlpWc1VXMlFnei04M1dRNWZIS2RCalVMWkVDaUZkNEJGZ0c1LVRmVDBrNHRKc09fcGQ5Y1hmSmhIMl9nM0xuS09lQnBMT2QyQzlkRHBTeHhFWFlwU2xiZzMtdUEyTmJadDdFaHczdU5DdmVmTV9Kei1Lak9YTFQ2ZDJheU5UVzNVT19sT3FJNFJTR0VUVzVtUWNuUGJQT3QyOFlyQ3BXQm9teFVNVjRVRzlMWG1YaFNRd2wwd3RnXzE5NENzY2JIaG5yVk0xVQ?oc=5","date":"2025-11-05","type":"pipeline","source":"PR Newswire","summary":"Rheumatoid Arthritis Market to Surge by 2034 as Next-Generation Biologics and JAK Inhibitors Gain Traction | DelveInsight - PR Newswire","headline":"Rheumatoid Arthritis Market to Surge by 2034 as Next-Generation Biologics and JAK Inhibitors Gain Traction | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1meU9qRVFja19ud1JFWDhiejAtZXg2UTBWbG9kYngtSjU4NEtjWVJfZkx6ZU1QYjFiN000WHRIQ1dFd2dRanNWSmFjVVRseEJWZXplQ1l3RWJ0Znk0ZnVj?oc=5","date":"2025-05-21","type":"pipeline","source":"Nature","summary":"Treatment satisfaction and associated factors among patients with rheumatoid arthritis in North West Ethiopia - Nature","headline":"Treatment satisfaction and associated factors among patients with rheumatoid arthritis in North West Ethiopia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNeDZxT1E1bm9CWTA1SzZ0X3FxcnhnYXVnQS1kU0hDSHN1R19aY29YYWZ3ZjJjcnZkUW1DckZ6Vnc5c0hKVXF6dVowYWdvUjdzQnllSGUyVUdEWGRMYm4yWG8tSkRVNnVZOVFqR2tnQ2RxdFJxdzFoRm96RmlYdDBlS0gtc0RFQVZwUEh6MVpaM0Z5SFR3LVdPTWJfQXZzcjZJc2lWd0NXMWxUczA5RWxhaDI1bDNVMHFvbmVnS3k0ODU5WTVvcEV3NFczNDlXdTN0Znc?oc=5","date":"2025-04-21","type":"pipeline","source":"Clinical Advisor","summary":"Biologic Drug Therapy in Severe Plaque Psoriasis With New-Onset Joint Pain - Clinical Advisor","headline":"Biologic Drug Therapy in Severe Plaque Psoriasis With New-Onset Joint Pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQLVFadWk3Y2hnWGFRdF9oZjZXQ3pVTjhMcmhwNWVJVUh2ZHliNlJ1cEN5aG5WQzRvSUdaenV0NjQ1OVVzMjdpNFJvWmxjRWwtMUlTbGJNV0tHR1pTeXcwLXJKc3RrQ2RiaUhqdzBSSUhmUHB5dUdaczd3SFo4eUlBQ0E1RHFXZUI2cFJ2MlZfSkZXcHhOdXh5VTRYM0xnY3FOcUN6UWtrMXJfV1BrdDB3d2RXbkFkWjVFc1haZkNWZDdsZFZ2a2pCa1dLQzB0UQ?oc=5","date":"2024-12-16","type":"pipeline","source":"Specialty Pharmacy Continuum","summary":"The Specialty Pharmacist’s Role in Rheumatoid Arthritis - Specialty Pharmacy Continuum","headline":"The Specialty Pharmacist’s Role in Rheumatoid Arthritis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNMm1FVm4tQ2V3Q2trbUswZDBEQW5yQ0VMVWpEZ3JKaVgwZGxhMjV1UFdncy1lNjJXd2hxaF9TZEpxYW5hbDQ2bFpYRV96RWZwUWFEUFBGdkJEZk1GNUNSYlR3ZzVFZFJYQTBBWWN4RWxDTnhDQ2pHbTh5MUtaZDlrM2pmTGRjZUxaTnlWR0RqcU4zeHlUOHBockRFSEc?oc=5","date":"2024-06-25","type":"pipeline","source":"Frontiers","summary":"COAST Development Group's international consensus guidelines for the treatment of canine osteoarthritis - Frontiers","headline":"COAST Development Group's international consensus guidelines for the treatment of canine osteoarthritis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1hd25nVS03Sk5fLThPNGt0cnMxVFJVdWJud3daSnBzVVBqa3BoUElYUWRXcVVINFB4YUVCV2FjVWt4aHBTZFplelhkdzY1eC1MOEdrZGdKTExpVXlybTZN?oc=5","date":"2022-06-27","type":"pipeline","source":"Nature","summary":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 - Nature","headline":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for p","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQdlNxZFBlNTF4X1NFRm8xdXZNVlVjOVRreHdPZXN0aklyMHV3c2QxYWpsSHF1UDFYWWp5RHpGcXRqWUZwOW1HUHNsOGhlaE1HZTFEcEhaNDZ5MnVwczZRUGo3eloyZHVpVFkyN0dHWlJkMjZ6dzE1WkNkRXJqa2lnQkl5dnZnNkJqdFUw?oc=5","date":"2021-08-22","type":"pipeline","source":"Arthritis Foundation","summary":"Leading the Way in Osteoarthritis Research - Arthritis Foundation","headline":"Leading the Way in Osteoarthritis Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5WclBqbGtDbFZqOVZfUHhsc3Y1SDZtUFdCQUI0aHBEV1E5cnRndk5FZnB1X2kxQmJoSXF1UGdNN0NGVGl4R1hsUHRFODZoTGpMOFMwcmVJRUlWdjFGNGowZ1JENEdrQWJzNVZ2V3B6VFVGX1dmVW40Zk9pZnhFUVk?oc=5","date":"2020-11-24","type":"pipeline","source":"chugai-pharm.co.jp","summary":"Chugai and DeNA Jointly Launch “Ring Again,” a Rheumatoid Arthritis Disease Awareness Project - chugai-pharm.co.jp","headline":"Chugai and DeNA Jointly Launch “Ring Again,” a Rheumatoid Arthritis Disease Awareness Project - chugai","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}